These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1700224)

  • 1. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine.
    Silver PJ; Buchholz A; Dundore RL; Harris AL; Pagani ED
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):501-5. PubMed ID: 1700224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
    Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
    J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
    Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
    J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction by (-)-cicletanine of the vascular reactivity to angiotensin II in rats.
    Alvarez-Guerra M; Alda O; Morin E; Allard M; Garay RP
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):564-70. PubMed ID: 8891883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant mechanism of the new vasodilator, FK409.
    Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
    Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
    Souness JE; Brazdil R; Diocee BK; Jordan R
    Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta.
    Schini V; Schoeffter P; Miller RC
    Br J Pharmacol; 1989 Jul; 97(3):853-65. PubMed ID: 2547488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
    Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
    Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC; Challiss RA; Boyle JP
    Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.